These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27517135)

  • 41. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
    Li F; Wang M; Wang J; Li R; Zhang Y
    Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trends.
    Hendricks AJ; Mills BW; Shi VY
    J Dermatol Sci; 2019 Aug; 95(2):56-61. PubMed ID: 31395434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Host dysbiosis negatively impacts IL-9-producing T-cell differentiation and antitumour immunity.
    Almeida RR; Vieira RS; Castoldi A; Terra FF; Melo ACL; Canesso MCC; Lemos L; Cipelli M; Rana N; Hiyane MI; Pearce EL; Martins FDS; Faria AMC; Câmara NOS
    Br J Cancer; 2020 Aug; 123(4):534-541. PubMed ID: 32499569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbiota and prebiotics modulation of uremic toxin generation.
    Koppe L; Fouque D
    Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contributions of the intestinal microbiome in lung immunity.
    McAleer JP; Kolls JK
    Eur J Immunol; 2018 Jan; 48(1):39-49. PubMed ID: 28776643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The potential of fecal microbiota transplantation in systemic sclerosis.
    Hoffmann-Vold AM; Fretheim H; Didriksen H; Molberg Ø
    Expert Rev Clin Immunol; 2020 Feb; 16(2):117-118. PubMed ID: 31858856
    [No Abstract]   [Full Text] [Related]  

  • 47. The microbiome of the critically ill patient.
    Akrami K; Sweeney DA
    Curr Opin Crit Care; 2018 Feb; 24(1):49-54. PubMed ID: 29257783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
    Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC
    Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The microbiome: current and future view of an ancient paradigm.
    Neish AS; Pacifici R; Mulle JG; Kraft CS; Stephens DS
    Future Microbiol; 2017 Aug; 12():831-834. PubMed ID: 28660775
    [No Abstract]   [Full Text] [Related]  

  • 54. Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: a systematic review.
    Lopes RCSO; Balbino KP; Jorge MP; Ribeiro AQ; Martino HSD; Alfenas RCG
    Nutr Hosp; 2018 Apr; 35(3):722-730. PubMed ID: 29974784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis.
    Lyu Y; Wu L; Wang F; Shen X; Lin D
    Exp Biol Med (Maywood); 2018 Apr; 243(7):613-620. PubMed ID: 29534601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation.
    Alagna L; Palomba E; Mangioni D; Bozzi G; Lombardi A; Ungaro R; Castelli V; Prati D; Vecchi M; Muscatello A; Bandera A; Gori A
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut Microbiota and Diarrhea: An Updated Review.
    Li Y; Xia S; Jiang X; Feng C; Gong S; Ma J; Fang Z; Yin J; Yin Y
    Front Cell Infect Microbiol; 2021; 11():625210. PubMed ID: 33937093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbiome and diabetes: Where are we now?
    Vallianou NG; Stratigou T; Tsagarakis S
    Diabetes Res Clin Pract; 2018 Dec; 146():111-118. PubMed ID: 30342053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy.
    Strouse C; Mangalam A; Zhang J
    Gut Microbes; 2019; 10(2):109-112. PubMed ID: 30183502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.